openPR Logo
Press release

Endometriosis Treatment Market is Expected to Reach $3.43 bn by 2027

02-11-2020 10:53 AM CET | Health & Medicine

Press release from: Optima insights Pvt Ltd

The Endometriosis Treatment Market was valued at US $2.64 billion in the year 2019 and is estimated to reach US $3.43 billion by 2027, at a CAGR of 3.36%.

The growth of tissue outside the uterus similar to lining of uterus (endometrium) refers to Endometriosis. Areas of endometrial tissue growth often occur in ovaries, fallopian tubes, peritoneum and outer surfaces of bladder, uterus, intestines, and rectum and rarely spread beyond pelvic organs. During the menstrual cycle thickened tissue breaks down and bleeds. If the tissue is trapped, it results in the scarring and adhesion, causing inflammation and pain. Symptoms include pain during periods, painful urination, painful bowel movements, fatigue and infertility.

The possible causative factors for endometriosis include retrograde menstruation, peritoneal & embryonic cell transformation, surgical scar implantation, endometrial cell transport and immune system disorders.

Global prevalence of endometriosis is about 176 million of which 30-50% are affected by infertility while 71-85% of the women with chronic pelvic pain are affected by endometriosis.. According to International Journal of Obstetrics & Gynecology, there is an increase of 1.6% in endometriosis prevalence with incidence rates peaking in women aged between 25 and 39 years.

The major drivers of endometriosis treatment market include growing prevalence of endometriosis, increased awareness and significance of women health. The key restraints include unavailability of non-invasive diagnostic tests and lack of treatment adherence by patients. Improving Quality of Life and development of techniques for early diagnosis of endometriosis are the unmet needs in the market. Besides advanced treatment options replacing hormonal therapies will gain more attention in the forecast period.

Request for Sample Pages @ https://www.optimainsights.org/sample-request/212-endometriosis-treatment-market

Major companies for Endometriosis treatment market include and many more Takeda Pharmaceutical Company, Bayer AG, Eli Lilly & Company, AstraZeneca Plc., Astellas Pharma Inc., AbbVie Inc., Pfizer Inc and many more.... According to clinicaltrials.gov, there are around 152 active trials for the treatment of Endometriosis.

Recent Updates

ObsEva is developing pipeline product, Linzagolix for the treatment of endometriosis

Relugolix, investigational drug candidate under phase III for endometriosis developing by Myovant sciences

Evotec and Bayer advance third endometriosis program into Phase I clinical development

Forendo's lead program, HSD17B1 inhibitor FOR-6219, targeted for endometriosis, is in phase Ib clinical studies

Based on Treatment Class (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn):

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Oral Contraceptives

Gonadotropins releasing hormone agonists

Hormonal Intra Uterine Devices (IUD)

Progestin Therapy

Aromatase Inhibitors

Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

North America

Europe

APAC

LAMEA

Research Scope

Provides a detailed Analysis of the Market Structure along with forecast of the various segments and sub-segments.

Provides a Comparative Analysis of Key Marketed and Pipeline Products.

Provides Key Information on Players involved.

Provides a Complete Overview of Market Segments and the Regional Outlook.

Provides In-depth Coverage of Key News, including Major Mergers, Acquisitions and Product Development updates such as clinical trial progression updates and regulatory updates.

The Report Provides Key Insights on

History of the Endometriosis Treatment Market, 2015 to 2018

Forecast of the Endometriosis Treatment Market Growth till the year 2027

The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Endometriosis Treatment Market

Analysis of potential growth segments which will drive the market

Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market

Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics

Download Complete TOC of the Report @ https://www.optimainsights.org/request-toc/212-endometriosis-treatment-market

Contact

Optima Insights

Mr Chucks G

+91 966 6620 365 (Asia) | +1 424 2554 365 (US)

Email: sales@optimainsights.org

https://www.optimainsights.org

About Us

Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endometriosis Treatment Market is Expected to Reach $3.43 bn by 2027 here

News-ID: 1927294 • Views: 464

More Releases from Optima insights Pvt Ltd

Inflammatory Bowel Disease (IBD) Treatment Market is Expected to Reach $15.5 bn …
The Inflammatory Bowel Disease (IBD) treatment market share was US$ 11.38 Bn in the year 2018. The market is anticipated to grow at a rate of 3.94%, through the forecast period to reach US$ 15.5 Bn by the year 2027. Inflammatory Bowel Disease (IBD) usually denotes disorders characterized by the inflammation in the digestive system. Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome are two different disorders that are often confused
Polycystic Ovarian Syndrome (PCOS) Treatment Market is Expected to Reach $5.59 b …
The Polycystic Ovarian Syndrome (PCOS) Treatment Market was valued at US $3.74 billion in the year 2019 and is estimated to reach US $5.59 billion by 2027, at a CAGR of 5.18%. Polycystic Ovarian Syndrome (PCOS), also referred to as Stein-Leventhal syndrome is a hormonal disorder characterized by enlarged ovaries and formation of numerous small cysts (fluid-filled sacs) on the outer edges of the ovaries. Symptoms of PCOS include irregular periods,
Veterinary Vaccines Market is Expected to Reach $13.51 bn by 2027
The Veterinary Vaccines Market was valued at US $7.91 billion in the year 2018 and is estimated to reach US $13.51 billion by 2027, at a CAGR of 6.13%. Generally, vaccines are effective in preventing infectious diseases. Veterinary vaccines especially reduce the burden of the disease in animals and also helps in preventing several zoonotic diseases also. There are four types of veterinary vaccines available depending on preparation type, they are
Animal Feed Additives Market is Expected to Reach $47.75 bn by 2026
The Animal Feed Additives Market was valued at US$35.82 billion in the year 2018 and is estimated to reach US$47.75 billion by 2026, at a CAGR of 3.66%. Feed additives are substances that enhance the nutritional efficiency of animals. The use of additives in veterinary feed is practiced from the early 1960s, especially, antibiotics are an integral part of veterinary health. Besides, several feed additives including probiotics, amino acids, vitamins and

All 5 Releases


More Releases for Endometriosis

Endometriosis Market Trends, Size, Forecast - 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and
Global Endometriosis Treatment Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on Endometriosis Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/817758/global-endometriosis-treatment-market-insights   Therapies used to treat endometriosis include: Hormonal contraceptives. Birth
Endometriosis-Pipeline Review H2 2018
Endometriosis-Pipeline Review, H2 2018 Summary Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis-Pipeline Review, H2 2018, provides an overview of the Endometriosis (Women's Health) pipeline landscape. Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding. Risk factors age, uterine abnormalities, history of pelvic infection and family history. Treatment
Endometriosis Treatment Market Outlook, and Opportunity Analysis, 2018 – 2026
Endometriosis is a painful medical condition in which the tissue that lines in the inner part of the uterus i.e. endometrium grows outside the uterus. Endometriosis tissue is found in fallopian tubes, ovaries, and tissue lining the pelvis. In endometriosis, endometrial tissue which is displaced acts in the usual way i.e. it thickens, breaks down and eventually bleeds like in every menstrual cycle. As the displaced tissue has no other
Global Endometriosis Market Research and Forecast 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and
Endometriosis Treatment Market Intelligence with Competitive Landscape 2024
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel, or tissue lining of the pelvic floor. This disease affects over 170 million women across the globe. Endometriosis has an unclear etiology and complex symptoms. Hence, the endometriosis treatment market is projected to grow substantially due to increase in number of cases for endometriosis and